Education
About Us
Working with TipRanks
Follow Us
Treace Medical Concepts (TMCI)
NASDAQ:TMCI
TMCI Stock Chart & Stats
Day’s Range― - ―
52-Week Range$4.54 - $10.79
Previous CloseN/A
Volume76.56K
Average Volume (3M)375.61K
Market Cap
$452.95M
Enterprise Value$371.29M
Total Cash (Recent Filing)$69.29M
Total Debt (Recent Filing)$70.09M
Price to Earnings (P/E)―
Beta1.99
Next Earnings
Nov 11, 2025EPS Estimate
-0.28Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.28
Shares Outstanding63,173,126
10 Day Avg. Volume335,020
30 Day Avg. Volume375,606
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market Cap0.82
Enterprise Value/Revenue1.74
Enterprise Value/Gross Profit2.17
Enterprise Value/Ebitda-10.76
Forecast
1Y Price Target
$8.58Price Target Upside19.67% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering6
Bulls Say, Bears Say
Bulls Say
Market ExpansionThe company's expansion into a broader range of bunion-corrective technologies allows it to penetrate the remaining 70% of the market it previously couldn't access.
Product PortfolioPhysicians at the event spoke about the key features and advantages of TMCI's product portfolio and the ability to address a broader segment of the bunion market.
Bears Say
Competitive PressureThere is a concern that TMCI’s growth may stall if competitors launch similar products.
Growth Rate ComparisonTMCI is expected to grow at an 8% 3-year CAGR, which is below the 18% 3-year CAGR growth rate of its peers, leading to a valuation discount.
Treace Medical Concepts News
TMCI FAQ
What was Treace Medical Concepts’s price range in the past 12 months?
Treace Medical Concepts lowest stock price was $4.54 and its highest was $10.79 in the past 12 months.
What is Treace Medical Concepts’s market cap?
Treace Medical Concepts’s market cap is $452.95M.
When is Treace Medical Concepts’s upcoming earnings report date?
Treace Medical Concepts’s upcoming earnings report date is Nov 11, 2025 which is in 65 days.
How were Treace Medical Concepts’s earnings last quarter?
Treace Medical Concepts released its earnings results on Aug 07, 2025. The company reported -$0.28 earnings per share for the quarter, beating the consensus estimate of -$0.288 by $0.008.
Is Treace Medical Concepts overvalued?
According to Wall Street analysts Treace Medical Concepts’s price is currently Undervalued.
Does Treace Medical Concepts pay dividends?
Treace Medical Concepts does not currently pay dividends.
What is Treace Medical Concepts’s EPS estimate?
Treace Medical Concepts’s EPS estimate is -0.28.
How many shares outstanding does Treace Medical Concepts have?
Treace Medical Concepts has 63,173,126 shares outstanding.
What happened to Treace Medical Concepts’s price movement after its last earnings report?
Treace Medical Concepts reported an EPS of -$0.28 in its last earnings report, beating expectations of -$0.288. Following the earnings report the stock price went up 7.923%.
Which hedge fund is a major shareholder of Treace Medical Concepts?
Currently, no hedge funds are holding shares in TMCI
Treace Medical Concepts Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$8.58 (19.67% Upside)
$8.58 (19.67% Upside)
Blogger Sentiment
Bullish
TMCI Sentiment 100%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Increased
By 145.5K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.2%
Last 30 Days ▼ 3.7%
Last 30 Days ▼ 3.7%
News Sentiment
Neutral
Bullish news 59%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Negative
20 days / 200 days
Momentum
31.55%
12-Months-Change
Fundamentals
Return on Equity
-46.89%
Trailing 12-Months
Asset Growth
-8.69%
Trailing 12-Months
Company Description
Treace Medical Concepts
Treace Medical Concepts, Inc., an orthopedic medical device company, engages in the design, manufacture, and marketing of medical devices for foot and ankle surgeons in the United States. It offers Lapiplasty procedure that allows podiatric surgeons to treat all three dimensions of the bunion, providing patients with a cosmetic and medical improvement. The company also provides Lapiplasty Mini-Incision precision system. In addition, it offers products to address ancillary surgical procedures, including akin osteotomies, weil osteotomies, intercuneiform stabilization, lesser tarsometatarsal joint fusions, and autograft bone harvesting, as well as for MTP fusion. Treace Medical Concepts, Inc. was founded in 2013 and is headquartered in Ponte Vedra Beach, Florida.
TMCI Earnings Call
Q2 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
Treace Medical Concepts reported solid revenue growth and successful product expansion, with strong financial management and strategic initiatives poised for future growth. However, the company still faces challenges with a net loss and slight gross margin decline. Overall, the outlook remains positive, with expectations for a stronger second half of 2025.View all TMCI earnings summariesTMCI Stock 12 Month Forecast
Average Price Target
$8.58
▲(19.67% Upside)
Technical Analysis
Ownership Overview
30.38% Insiders
12.02% Mutual Funds
26.67% Other Institutional Investors
18.96% Public Companies and
Individual Investors